These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9226994)

  • 1. Schizophrenia and L-745,870, a novel dopamine D4 receptor antagonist.
    Bristow LJ; Kramer MS; Kulagowski J; Patel S; Ragan CI; Seabrook GR
    Trends Pharmacol Sci; 1997 Jun; 18(6):186-8. PubMed ID: 9226994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 and D4 receptor ligands: relation to antipsychotic action.
    Wilson JM; Sanyal S; Van Tol HH
    Eur J Pharmacol; 1998 Jun; 351(3):273-86. PubMed ID: 9721018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The discovery of potent and selective dopamine D4 receptor antagonists.
    Faraci WS; Zorn SH; Sanner MA; Fliri A
    Curr Opin Chem Biol; 1998 Aug; 2(4):535-40. PubMed ID: 9736928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS; Last B; Getson A; Reines SA
    Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze.
    Cao BJ; Rodgers RJ
    Eur J Pharmacol; 1997 Sep; 335(2-3):117-25. PubMed ID: 9369363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ; Collinson N; Cook GP; Curtis N; Freedman SB; Kulagowski JJ; Leeson PD; Patel S; Ragan CI; Ridgill M; Saywell KL; Tricklebank MD
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1256-63. PubMed ID: 9400001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The D2 receptor: love it and leave it.
    Pickar D
    Mol Psychiatry; 1998 Mar; 3(2):101-2. PubMed ID: 9577830
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of L-745,870, a dopamine D4 receptor antagonist, on naloxone-induced morphine dependence in mice.
    Mamiya T; Matsumura T; Ukai M
    Ann N Y Acad Sci; 2004 Oct; 1025():424-9. PubMed ID: 15542745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor.
    Gazi L; Bobirnac I; Danzeisen M; Schüpbach E; Bruinvels AT; Geisse S; Sommer B; Hoyer D; Tricklebank M; Schoeffter P
    Br J Pharmacol; 1998 Jul; 124(5):889-96. PubMed ID: 9692773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional role of dopamine D4 receptor in schizophrenia].
    Semba J
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2004 Feb; 24(1):13-20. PubMed ID: 15027326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D
    Miyauchi M; Neugebauer NM; Meltzer HY
    J Psychopharmacol; 2017 Apr; 31(4):442-452. PubMed ID: 28347261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D4 receptors: a new opportunity for research on schizophrenia.
    Liégeois J; Eyrolles L; Bruhwyler J; Delarge J
    Curr Med Chem; 1998 Apr; 5(2):77-100. PubMed ID: 9481035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S 18126 ([2-[4-(2,3-dihydrobenzo[1,4]dioxin-6-yl)piperazin-1-yl methyl]indan-2-yl]), a potent, selective and competitive antagonist at dopamine D4 receptors: an in vitro and in vivo comparison with L 745,870 (3-(4-[4-chlorophenyl]piperazin-1-yl)methyl-1H-pyrrolo[2, 3b]pyridine) and raclopride.
    Millan MJ; Newman-Tancredi A; Brocco M; Gobert A; Lejeune F; Audinot V; Rivet JM; Schreiber R; Dekeyne A; Spedding M; Nicolas JP; Peglion JL
    J Pharmacol Exp Ther; 1998 Oct; 287(1):167-86. PubMed ID: 9765336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of selective dopamine D4 receptor blockers, NRA0160 and L-745,870, on A9 and A10 dopamine neurons in rats.
    Kawashima N; Okuyama S; Omura T; Chaki S; Tomisawa K
    Life Sci; 1999; 65(24):2561-71. PubMed ID: 10619364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D4 receptors and development of newer antipsychotic drugs.
    Kulkarni SK; Ninan I
    Fundam Clin Pharmacol; 2000; 14(6):529-39. PubMed ID: 11206702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. F15063, a compound with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. II. Activity in models of positive symptoms of schizophrenia.
    Depoortère R; Bardin L; Auclair AL; Kleven MS; Prinssen E; Colpaert F; Vacher B; Newman-Tancredi A
    Br J Pharmacol; 2007 May; 151(2):253-65. PubMed ID: 17375086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human D2 and D4 dopamine receptors couple through betagamma G-protein subunits to inwardly rectifying K+ channels (GIRK1) in a Xenopus oocyte expression system: selective antagonism by L-741,626 and L-745,870 respectively.
    Pillai G; Brown NA; McAllister G; Milligan G; Seabrook GR
    Neuropharmacology; 1998 Aug; 37(8):983-7. PubMed ID: 9833627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A series of 6- and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: discovery of a potential atypical antipsychotic agent.
    Belliotti TR; Wustrow DJ; Brink WA; Zoski KT; Shih YH; Whetzel SZ; Georgic LM; Corbin AE; Akunne HC; Heffner TG; Pugsley TA; Wise LD
    J Med Chem; 1999 Dec; 42(25):5181-7. PubMed ID: 10602703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.
    Patel S; Patel S; Marwood R; Emms F; Marston D; Leeson PD; Curtis NR; Kulagowski JJ; Freedman SB
    Mol Pharmacol; 1996 Dec; 50(6):1658-64. PubMed ID: 8967990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition.
    Mansbach RS; Brooks EW; Sanner MA; Zorn SH
    Psychopharmacology (Berl); 1998 Jan; 135(2):194-200. PubMed ID: 9497025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.